I agree, TP it's all about Kevetrin! Seems like others have forgotten that, or for some reason feel its not necessary to keep shareholders updated on the DF trials.Frankly, I dont care about Prurisol or Brilacidin. (Yes, I understand the potential for partnership or licensing to provide funds for future trials) What happened to p21 markers?  . . . that was April . . . are we still waiting on the queue?